SunValley Arthritis Center, Ltd.

Peoria, Arizona 85381

2 studies enrolling now · 19 studies all time

What they study most

Acute Gout, Ankylosing Spondylitis, Arthritis, Crohn's Disease, Enteropathic Arthritis, Inflammatory Arthritis, Polymyalgia Rheumatica, Postmenopausal Osteoporosis, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis

Studies at this site

• A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors) — Recruiting now
• RA-PRO PRAGMATIC TRIAL — Recruiting now
• Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) — Running, not enrolling
• A Study of Baricitinib in Participants With Rheumatoid Arthritis — Completed
• Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR) — Completed
• Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis — Completed
• An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed
• Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate — Completed
• Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) — Completed
• A Study of ARRY-371797 in Patients With Rheumatoid Arthritis — Completed
• Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis — Completed
• A Study in Moderate to Severe Rheumatoid Arthritis — Completed
• Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis — Completed
• A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). — Completed
• Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia — Completed
• Efficacy, Safety and Tolerability of ACZ885 in Patients With Active Rheumatoid Arthritis — Completed
• Abatacept Versus Adalimumab Head-to-Head — Completed
• Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study. — Completed
• Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis — Completed